Position in ABOS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$341,216
-$10,952 QoQ
Shares Held
144,584
-13.4% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 84 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 38.08374370608089.ToString("F0")%
Shared 0.ToString("F0")%
None 61.916256293919105.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. ABOS ranks #303 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ABOS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $341,216 | 144,584 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $352,168 | 166,905 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $255,474 | 149,401 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $178,345 | 153,748 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $167,898 | 152,636 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $457,889 | 266,216 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $593,214 | 239,200 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $212,496 | 87,809 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $197,282 | 48,712 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $88,803 | 23,126 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $92,290 | 22,239 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $73,705 | 15,324 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $209,120 | 51,508 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $138,692 | 25,684 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $189,706 | 18,914 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $113,724 | 24,197 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $53,514 | 13,687 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $139,477 | 20,633 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,455 | 569 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||